Trade Mark Journal No.2026/002 9 January 2026
WO0000001878480 (5)
Office of origin: United States of America
Date of International Registration:3 September 2025
Date of designation in the UK:
3 September 2025

International priority date claimed: 27 May 2025
(United States of America)
(99203964)
- Class 5
- Pharmaceutical preparations for use in the area of mental health care and the treatment of central nervous system diseases and disorders.
VistaGen Therapeutics, Inc.
Representative: David Lipson RAPHAEL BELLUM PLLC, 3190 Fairview Park Drive, Suite 550, Falls Church VA 22042, UNITED STATES OF AMERICA